Lars Hangartner

5.4k total citations · 2 hit papers
39 papers, 3.6k citations indexed

About

Lars Hangartner is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Lars Hangartner has authored 39 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 17 papers in Virology and 17 papers in Epidemiology. Recurrent topics in Lars Hangartner's work include HIV Research and Treatment (17 papers), Immune Cell Function and Interaction (13 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Lars Hangartner is often cited by papers focused on HIV Research and Treatment (17 papers), Immune Cell Function and Interaction (13 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Lars Hangartner collaborates with scholars based in United States, Switzerland and United Kingdom. Lars Hangartner's co-authors include Dennis R. Burton, Ann J. Hessell, Hans Hengartner, Rolf M. Zinkernagel, Meredith Hunter, Paul W.H.I. Parren, Preston A. Marx, Gary Landucci, Donald N. Forthal and Pascal Poignard and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Lars Hangartner

38 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fc receptor but not complement binding is important in antibody protection against HIV

2007 693 citations Ann J. Hessell, Lars Hangartner et al. profile →
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design

2016 385 citations Dennis R. Burton, Lars Hangartner profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Hangartner United States	25	1.9k	1.9k	963	908	861	39	3.6k
Bimal K. Chakrabarti United States	28	1.8k 1.0×	2.4k 1.3×	886 0.9×	948 1.0×	1.1k 1.3×	55	3.6k
Celia C. LaBranche United States	33	1.8k 0.9×	2.8k 1.5×	881 0.9×	1.2k 1.3×	1.3k 1.5×	149	3.9k
Jorma Hinkula Sweden	38	2.3k 1.2×	2.4k 1.3×	1.1k 1.2×	1.3k 1.4×	1.3k 1.5×	162	4.5k
Devin Sok United States	33	1.8k 1.0×	2.9k 1.5×	728 0.8×	2.1k 2.3×	1.4k 1.6×	51	4.6k
Abraham Pinter United States	43	2.1k 1.1×	3.4k 1.8×	1.1k 1.2×	1.3k 1.4×	1.9k 2.2×	117	5.0k
Anna Gazumyan United States	38	2.5k 1.3×	1.4k 0.7×	731 0.8×	1.6k 1.8×	1.5k 1.8×	61	5.2k
Bianca R. Mothé United States	26	2.5k 1.3×	2.3k 1.2×	912 0.9×	1.4k 1.5×	1.1k 1.2×	40	4.2k
Karina Yusim United States	25	1.2k 0.6×	2.0k 1.1×	1.0k 1.1×	1.3k 1.4×	1.1k 1.3×	39	3.5k
David T. Evans United States	32	2.2k 1.2×	2.5k 1.4×	1.2k 1.2×	629 0.7×	1.0k 1.2×	83	3.9k
Nicole A. Doria‐Rose United States	29	1.5k 0.8×	2.3k 1.3×	533 0.6×	946 1.0×	924 1.1×	68	3.0k

Countries citing papers authored by Lars Hangartner

Since Specialization

Citations

This map shows the geographic impact of Lars Hangartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Hangartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Hangartner more than expected).

Fields of papers citing papers by Lars Hangartner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Hangartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Hangartner. The network helps show where Lars Hangartner may publish in the future.

Co-authorship network of co-authors of Lars Hangartner

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Hangartner. A scholar is included among the top collaborators of Lars Hangartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Hangartner. Lars Hangartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Puig, Eduard, Rebecca Nedellec, Raiza Bastidas, et al.. (2025). Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelope. Cell Reports. 44(4). 115331–115331. 1 indexed citations

Rosato, Pamela C., Sahar Lotfi‐Emran, Vineet Joag, et al.. (2023). Tissue-resident memory T cells trigger rapid exudation and local antibody accumulation. Mucosal Immunology. 16(1). 17–26. 15 indexed citations

Turner, Hannah L., Abigail M. Jackson, Sara T. Richey, et al.. (2023). Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping. STAR Protocols. 4(3). 102476–102476. 11 indexed citations

Hangartner, Lars, Eva G. Rakasz, Rebecca Nedellec, et al.. (2021). Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primates. Science Translational Medicine. 13(585). 26 indexed citations

Bhat, Menakshi, Qian Wu, Erik Pong, et al.. (2021). Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis. The Journal of Immunology. 206(6). 1284–1296. 6 indexed citations

Pauthner, Matthias & Lars Hangartner. (2020). Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design. Current topics in microbiology and immunology. 428. 31–87. 4 indexed citations

Bianchi, Matteo, Hannah L. Turner, Bartek Nogal, et al.. (2018). Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization. Immunity. 49(2). 288–300.e8. 113 indexed citations

Kouyos, Roger D., et al.. (2015). The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals. AIDS. 29(14). 1803–1810. 6 indexed citations

McGuire, Andrew T., Kristen W. Cohen, Roland K. Strong, et al.. (2013). Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs. PLoS Pathogens. 9(1). e1003106–e1003106. 132 indexed citations

10.

Hessell, Ann J., Eva G. Rakasz, Pascal Poignard, et al.. (2009). Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers. PLoS Pathogens. 5(5). e1000433–e1000433. 403 indexed citations

11.

Hessell, Ann J., Pascal Poignard, Meredith Hunter, et al.. (2009). Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nature Medicine. 15(8). 951–954. 417 indexed citations

12.

Schildknecht, Anita, et al.. (2008). Absence of CTL Responses to Early Viral Antigens Facilitates Viral Persistence. The Journal of Immunology. 180(5). 3113–3121. 16 indexed citations

13.

Law, Mansun & Lars Hangartner. (2008). Antibodies against viruses: passive and active immunization. Current Opinion in Immunology. 20(4). 486–492. 37 indexed citations

14.

Zúñiga, Armando, Zili Wang, Matthias Liniger, et al.. (2007). Attenuated measles virus as a vaccine vector. Vaccine. 25(16). 2974–2983. 70 indexed citations

15.

Recher, Mike, Karl S. Lang, Alexander A. Navarini, et al.. (2007). Extralymphatic virus sanctuaries as a consequence of potent T-cell activation. Nature Medicine. 13(11). 1316–1323. 43 indexed citations

16.

Hangartner, Lars, Raphaël M. Zellweger, Jacqueline Weber, et al.. (2006). Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread. The Journal of Experimental Medicine. 203(8). 2033–2042. 43 indexed citations

17.

Hangartner, Lars, Rolf M. Zinkernagel, & Hans Hengartner. (2006). Antiviral antibody responses: the two extremes of a wide spectrum. Nature reviews. Immunology. 6(3). 231–243. 244 indexed citations

18.

McCoy, Kathy D., Nicola Harris, Bernhard Odermatt, et al.. (2006). Natural IgE Production in the Absence of MHC Class II Cognate Help. Immunity. 24(3). 329–339. 101 indexed citations

19.

Zellweger, Raphaël M., Lars Hangartner, Jacqueline Weber, R M Zinkernagel, & Hans Hengartner. (2006). Parameters governing exhaustion of rare T cell‐independent neutralizing IgM‐producing B cells after LCMV infection. European Journal of Immunology. 36(12). 3175–3185. 12 indexed citations

20.

Hangartner, Lars, et al.. (2001). Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. Vaccine. 19(17-19). 2329–2336. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact